Aadi Bioscience (AADI) Stock Forecast & Price Target

$2.37 -0.02 (-0.84%)

(As of 10:33 AM ET)

Aadi Bioscience - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 5 Analyst Ratings

Sell
0

Hold
5

Buy
0

Based on 5 Wall Street analysts who have issued ratings for Aadi Bioscience in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 5 have given a hold rating for AADI.

Consensus Price Target

$1.67
-29.68% Downside

According to the 5 analysts' twelve-month price targets for Aadi Bioscience, the average price target is $1.67. The highest price target for AADI is $1.75, while the lowest price target for AADI is $1.50. The average price target represents a forecasted downside of -29.68% from the current price of $2.37.

Get the Latest News and Ratings for AADI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Aadi Bioscience and its competitors.

AADI Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	1 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$1.67	$1.67	$10.25	$24.67
Forecasted Upside	-29.68% Downside	-22.48% Downside	460.11% Upside	1,016.14% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

Is the Trump/Musk duo good for shares of TSLA? (Ad)

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.

AADI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AADI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Aadi Bioscience Stock vs. The Competition

Type	Aadi Bioscience	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	-30.26% Downside	28,675.54% Upside	12.02% Upside
News Sentiment Rating	Positive News See Recent AADI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/27/2024	Piper Sandler Companies 5 of 5 stars		Downgrade	Overweight ➝ Neutral	$1.75
8/21/2024	Jefferies Financial Group 2 of 5 stars		Downgrade	Buy ➝ Hold	$11.00 ➝ $1.50
8/21/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Neutral
8/21/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Bancroft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/11/2023	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$47.00 ➝ $33.00	+366.10%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:57 AM ET.

AADI Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Aadi Bioscience is $1.67, with a high forecast of $1.75 and a low forecast of $1.50.
: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aadi Bioscience in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AADI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AADI, but not buy additional shares or sell existing shares.
: According to analysts, Aadi Bioscience's stock has a predicted downside of -29.68% based on their 12-month stock forecasts.
: Analysts like Aadi Bioscience less than other "medical" companies. The consensus rating for Aadi Bioscience is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AADI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Is the Trump/Musk duo good for shares of TSLA? (Ad)

Discover how to trade Tesla, simply follow this link here.

This page (NASDAQ:AADI) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aadi Bioscience (AADI) Stock Forecast & Price Target